dc.creatorBELLESSO, Marcelo
dc.creatorCOSTA, Silvia Figueiredo
dc.creatorPRACCHIA, Luis Fernando
dc.creatorDIAS, Lucia Cristina Santos
dc.creatorCHAMONE, Dalton
dc.creatorDORLHIAC-LLACER, Pedro Enrique
dc.date.accessioned2012-10-19T17:08:48Z
dc.date.accessioned2018-07-04T15:05:30Z
dc.date.available2012-10-19T17:08:48Z
dc.date.available2018-07-04T15:05:30Z
dc.date.created2012-10-19T17:08:48Z
dc.date.issued2011
dc.identifierANNALS OF HEMATOLOGY, v.90, n.4, p.455-462, 2011
dc.identifier0939-5555
dc.identifierhttp://producao.usp.br/handle/BDPI/21677
dc.identifier10.1007/s00277-010-1073-3
dc.identifierhttp://dx.doi.org/10.1007/s00277-010-1073-3
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1618451
dc.description.abstractThe purpose of this study was to evaluate outcomes such as success of the initial therapy, failure of outpatient treatment, and death in outpatient treatment during intravenous antimicrobial therapy in patients with febrile neutropenia (FN) and hematological malignancies. In addition, clinical and laboratory data and the Multinational Association for Supportive Care of Cancer index (MASCC) were compared with failure of outpatient treatment and death. In a retrospective study, we evaluated FN following chemotherapy events that were treated initially with cefepime, with or without teicoplanin and replaced by levofloxacin after 48 h of defervescence in patients with good general conditions and ANC > 500/mm(3). Of the 178 FN episodes occurred in 126 patients, we observed success of the initial therapy in 63.5% of the events, failure of outpatient treatment in 20.8%, and death in 6.2%. The success rate of oral levofloxacin after defervescence was 99% (95 out of 96). Using multivariate analysis, significant risks of failure of outpatient treatment were found to be smoking (odds ratio (OR) 3.14, confidence interval (CI) 1.14-8.66; p = 0.027) and serum creatinine levels > 1.2 mg/dL (OR 7.97, CI 2.19-28.95; p = 0.002). With regard to death, the risk found was oxygen saturation by pulse oximetry < 95% (OR 5.8, IC 1.50-22.56; p = 0.011). Using the MASCC index, 165 events were classified as low risk and 13 as high risk. Failure of outpatient treatment was reported in seven (53.8%) high-risk and 30 (18.2%) low-risk episodes (p = 0.006). In addition, death occurred in seven (4.2%) low-risk and four (30.8%) high-risk events (p = 0.004). Ours results show that MASCC index was able to identify patients with high risk. In addition, non-smoking, serum creatinine levels a parts per thousand currency sign1.2 mg/dL, and oxygen saturation by pulse oximetry a parts per thousand yen95% were protection factors.
dc.languageeng
dc.publisherSPRINGER
dc.relationAnnals of Hematology
dc.rightsCopyright SPRINGER
dc.rightsrestrictedAccess
dc.subjectFebrile neutropenia
dc.subjectMASCC
dc.subjectOutpatient treatment
dc.titleOutpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución